Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

MAb for non-Hodgkin's lymphoma now available in U.S.

Dec. 19, 1997

Novopharm Biotech's hMAb enters phase I in Canada

Dec. 19, 1997

Seragen reports preliminary results of pivotal CTCL study

Dec. 17, 1997

Phase II results reported for Bexxar

Dec. 15, 1997

Cel-Sci expands Multikine trial

Dec. 12, 1997

New data on PDL's SMART M195 antibody reported

Dec. 12, 1997

FDA approves Neoprobe's IND for RIGS/ACT therapy

Dec. 11, 1997

ImmunoGen's C242-DM1 found safe in preclinical studies

Dec. 10, 1997

ImClone and Merck KGaA expand collaboration for BEC2 cancer vaccine

Dec. 10, 1997

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...